mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.09 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |